Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent publications published by researchers at the MRC WIMM.

Innate Lymphocyte Mechanisms in Skin Diseases.

Book

Chen Y-L. et al, (2020), 38, 171 - 202

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation.

Journal article

Chen Y-L. et al, (2020), J Exp Med, 217

Natural killer cells get under your skin.

Journal article

Ogg G., (2020), Sci Transl Med, 12

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Journal article

Luo J. et al, (2019), J Allergy Clin Immunol, 144, 1722 - 1726.e10

Atopic dermatitis epidemiology and unmet need in the United Kingdom.

Journal article

Cork MJ. et al, (2019), J Dermatolog Treat, 1 - 9

Capturing the antigen landscape: HLA-E, CD1 and MR1.

Journal article

Ogg G. et al, (2019), Curr Opin Immunol, 59, 121 - 129

FEVIPIPRANT INHIBITS PROSTAGLANDIN D2 MEDIATED ACTIVATION OF GROUP 2 INNATE LYMPHOID CELLS (ILC2S)

Conference paper

Sandham D. et al, (2019), RESPIROLOGY, 24, 105 - 105

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection.

Journal article

Jayathilaka D. et al, (2018), Nat Commun, 9

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Conference paper

Chen W. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Type-2 CD8+T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Conference paper

Hinks T. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma.

Journal article

Hilvering B. et al, (2018), Mucosal Immunol, 11, 1408 - 1419

Load More